61РЕЗУЛЬТАТИ ДИСЕРТАЦІЙНИХ ТА НАУКОВО – ДОСЛІДНИХ РОБІТ/ RESULTS OF DISSERTATIONS AND RESEARCH WORKS
UDC: 616.34-008.1-053.2-079.4-085.874.2:613.263
DOI: 10.24061/2413-4260.XIІI.2.48.2023.9
G. Senatorova1, O. Omelchenko1, 
T. Teslenko1, G. Muratov2, N. Orlova1, 
K. Chatykian2  
Kharkiv National Medical University 
(Kharkiv, Ukraine)1
Kharkiv Regional Children’s Clinical Hospital
(Ukraine)2CHALLENGES IN DIFFERENTIAL 
DIAGNOSIS OF COELIAC DISEASE AND 
GLUTEN INTOLERANCE IN CHILDREN
Summary
Introduction. The group of gluten-dependent diseases currently comprises 3 pathological conditions: celiac disease, 
non-celiac gluten intolerance and wheat allergy. Celiac disease is a chronic, immune-inflammatory disease that occurs in 
genetically predisposed individuals in response to exposure to the main cereal protein - gluten. It is characterised by damage 
to the small intestinal mucosa, leading to its atrophy with corresponding intestinal and extraintestinal clinical manifestations. 
The treatment is a lifelong gluten-free diet. Gluten intolerance is a condition characterised by the onset of irritable bowel 
syndrome-like symptoms within hours or days of eating gluten-containing foods. These symptoms disappear quickly when the 
consumption of gluten-containing products is stopped. The causes of gluten intolerance are amylase inhibitors, trypsin and 
fructans (FODMAPS), which are present in wheat and other gluten-containing and gluten-free foods. New recommendations 
from the European Society of Paediatrics, Gastroenterology, Hepatology and Nutrition (ESPGHAN) for the diagnosis of 
celiac disease in children were published in 2020. The diagnosis of gluten intolerance requires the exclusion of celiac disease 
and wheat allergy.
The aim of the study was to determine the characteristics of the clinical course of celiac disease and gluten intolerance 
(analysis of intestinal and extraintestinal symptoms), serological and morphological features for differential diagnosis and 
management.
Material and methods. Thirty children aged 9 months to 11 years were included in the study for the period 2016-2023. 
Distribution by gender: 13 (43.3%) boys and 17 (56.6%) girls, p=0.1391. Patients were divided into two groups according 
to the diagnosis of celiac disease and gluten intolerance. The study included a detailed medical history, assessment of the 
child's examination and physical development. Determination of titer of IgA antibodies, IgA to tissue transglutaminase (tTG-
IgA), endomysial IgA (EMA-IgA), gliadin IgG, wheat IgE antibodies, endoscopy and morphological examination of duodenal 
mucosal biopsies. Descriptive analysis and comparison of two proportions were used. Non-parametric methods were used 
to test hypotheses. Logistic regression analysis using the relative risk index (RR) and its 95% confidence interval (CI). 
Differences in parameters were considered statistically significant when p<0.05.
The study was approved by the Commission on Biomedical Ethics for Compliance with Moral and Legal Rules of Medical-
Scientific Research of the Kharkiv National Medical University. It was confirmed that the research does not contradict the 
basic bioethical norms and complies with the main provisions of the Good Clinical Practice (1996), the Convention of 
the Council of Europe on Human Rights and Biomedicine (04.04.1997), the Declaration of Helsinki of the World Medical 
Association on the ethical principles of research involving human subjects (1964-2008), and the Order of the Ministry of 
Health of Ukraine No. 690 (23.09.2009) with amendments according to the Order of the Ministry of Health of Ukraine No. 
523 (12.07.2012). Both parents of the patients were informed about the purpose and procedures of the research and signed 
the informed consent for their children's participation in this study. 
Statistical analysis was performed using Statistica 7.0 StatSoft Inc.1984-2004, (serial number 12255555555, USA) and 
MedCalc version 14.8-© 1993-2014 MedCalc Software bvba (Acacialaan 22 B-8400 Ostend, Belgium). The procedures, logic 
and interpretation of the statistical parameters obtained in the mathematical and statistical analysis were based on generally 
accepted rules of medical and biological statistics. Descriptive analysis and comparison of two proportions were used. Non-
parametric methods were used to test hypotheses: Logistic regression analysis using the relative risk index (RR) and its 95% 
confidence interval (CI). Differences in parameters were considered statistically significant if p<0.05. Patients in the study 
were divided into two groups according to the diagnosis of celiac disease and gluten intolerance.
The presented article is a fragment of the scientific research of the Department of Paediatrics No.1 and Neonatology of 
the Kharkiv National Medical University: topic "Medical and social adaptation aspects of children with somatic pathology 
in modern conditions"; state registration No.0120U102471.
Results.  66.6% of children from the general cohort were diagnosed with celiac disease and 33.3% of children with gluten 
intolerance, p=0.0053. The mean age of the children with celiac disease was 8.4±1.0 years. Gender distribution of children 
with celiac disease - 50.0% boys, 50.0% girls, p=1.0000. The mean age of the children with gluten intolerance was 9.1±1.0 
years. The gender distribution of children with gluten intolerance was 70.0% boys and 30.0% girls, p=0.0001. In 65.0% 
of children with celiac disease, the diagnosis was confirmed at an earlier stage than in children with gluten intolerance, 
p=0.0350. A family history of autoimmune pathology was found in 40% of children with celiac disease. All patients with 
celiac disease were seropositive for serological biomarkers. IgA to tissue transglutaminase tTG-IgA was detected in 95.0% 
of children with celiac disease (RR=20.4; 95% CI 1.4-307.2; p=0.0292).
Diarrhoea and abdominal pain were found in 18/30 children from the general cohort (RR=0.8; 95% CI 0.4-1.4; p=0.5050), 
loss of appetite - in 17/30 children (RR=0.7; 95% CI 0.4-1.3; p=0. 2695), 15/30 children had constipation and poor weight 62gain (RR=0.7; 95% CI 0.3-1.5; p=0.4209), 14/30 children had delayed physical development and weakness (RR=0.9; 95% CI 
0.4-1.9; p=0.7929). One third of the children had hyperactivity and attention deficit syndrome, sleep disturbances. All children 
with celiac disease had various stages of small intestinal mucosal atrophy according to the Marsh-Oberhuber classification. 
No atrophic changes in the small intestinal mucosa were found in children with gluten intolerance (normal structure of villi 
and crypts), but infiltrative changes were found in 60% of these patients (increase in intraepithelial lymphocytes).
Conclusion.  Comparative analysis showed no significant differences in the clinical presentation of celiac disease and 
gluten intolerance. Autoimmune pathology was not found in the family history of children with celiac disease, whereas it 
was found in 40% of patients with celiac disease. The diagnosis of gluten intolerance is made in case of exclusion of family 
history of autoimmune nosology; absence of autoantibodies to tissue tranglutaminase and deaminated gliadin peptides, 
endomysial autoantibodies, which should be determined on a gluten-containing diet, and absence of specific IgE to wheat. All 
children with celiac disease had various stages of atrophy of the small intestinal mucosa according to the Marsh-Oberhuber 
classification, whereas no atrophic changes were found in children with gluten intolerance, but 60% of patients with gluten 
intolerance had infiltrative changes in the small intestinal mucosa.
Keywords:  Celiac Disease; Gluten Intolerance; Gluten-free Diet; Children.
Introduction
Despite significant advances in medical science 
in the diagnosis and treatment of gastrointestinal 
diseases, the improvement of diagnostic algorithms 
for diseases of the small intestine is an issue of 
current interest. The diagnosis of celiac disease is 
not without its difficulties. Celiac disease remains 
one of the most difficult to diagnose, but the 
differential diagnosis between celiac disease and 
gluten intolerance is even more challenging.
The group of gluten-dependent diseases includes 
3 pathological conditions:
1). Celiac disease (gluten enteropathy, nontropical 
sprue, Gi-Herter-Heibner disease, etc.) is a genetically 
determined autoimmune disease with predominant 
damage to the small intestine associated with gluten 
consumption. Celiac disease is characterised by a 
reversible atrophic enteropathy and the development 
of gluten-dependent clinical symptoms. 
2). Gluten intolerance is a diagnosis of exclusion 
in patients with a negative reaction of the body to 
the consumption of gluten-containing products in the 
absence of pathological signs characteristic of celiac 
disease. Symptoms disappear after the introduction 
of a gluten-free diet and reappear when the patient 
resumes gluten consumption.
3). Wheat allergy: This disease develops as a type 
of IgE-mediated allergic reaction in response to the 
ingestion of gluten-containing products.
Celiac disease occurs in 0.5-1% of the population 
in most countries [1]. According to the public 
organization "Ukrainian Celiac Association", the 
number of patients with celiac disease in Ukraine is 
about 2,000 and it is increasing every year.
The risk of developing celiac disease is significantly 
increased in first- and second-degree relatives of 
patients with celiac disease, type 1 diabetes, selective 
IgA deficiency, autoimmune thyroiditis, Turner 
syndrome, Williams syndrome [2].
Celiac disease often remains undiagnosed due to 
clinical polymorphism and non-specific symptoms 
that appear between 6 and 24 months after the 
introduction of gluten-containing foods into the 
diet [3]. There may be a latency period between 
gluten ingestion and clinical manifestation. The 
main gastrointestinal symptoms of celiac disease 
are chronic diarrhoea, anorexia, abdominal pain and 
bloating, weight loss; some children may vomit. 
Symptoms are usually different in infants and older 
children. All of the gastrointestinal symptoms listed are common in children under the age of three, while 
abdominal pain is typical in older children. Celiac 
disease may be associated with diarrhoea (stools 
are often large and foul-smelling) or constipation. 
Common extraintestinal manifestations include 
delayed linear growth and puberty, chronic anaemia, 
osteopenia, osteoporosis, dental enamel defects, 
irritability, chronic fatigue, neuropathy, arthritis, 
arthralgia, amenorrhoea, elevated liver enzymes, 
increased risk of malignant neoplasms. Depending 
on the clinical phenotype, there are typical, atypical, 
subclinical, symptomatic and asymptomatic celiac 
diseases. Different manifestations and clinical 
polymorphisms complicate the differential diagnosis 
among gluten-dependent diseases. Therefore, the 
diagnosis of celiac disease is based on a complex of 
clinical, serological and anamnestic data.
The first stage - determination of total 
immunoglobulin IgA levels and IgA to tissue 
transglutaminase (tTG-IgA) on a gluten-containing 
diet.
Children with tTG-IgA titres less than 10 times 
the upper limit of normal should have a biopsy to 
confirm the diagnosis. If the tTG-IgA titer is more 
than 10 times the reference value, the diagnosis of 
celiac disease can be confirmed without biopsy if 
endomysial antibodies (EMA-IgA) are present in the 
second blood serum sample. In children with low 
levels of total IgA (<0.2 g/l in children older than 
3 years), IgG to deaminated gliadin peptide (DGP), 
EMA or tTG should be determined. In children with 
low total IgA, the tTG-IgA test is invalid. In this 
case, IgG antibodies to tTG (tTG-IgG) and DGP-IgG 
should be determined [3]. If either or both of these 
IgG-based tests are elevated, the patient should be 
evaluated with an intestinal biopsy. Human leukocyte 
antigen (HLA) genetic testing is not mandatory in 
the case of a serologically confirmed diagnosis [4-7]. 
Endoscopy with biopsy of the small bowel mucosa is 
a separate diagnostic step. More than 4 biopsies should 
be taken from the distal part of the duodenum and more 
than 1 from its bulb. The modified Marsh classification 
is used to assess damage to the small intestinal villi in 
gluten-dependent cases. Children with very high tTG-
IgA levels, positive anti-endomysial antibodies (EMA) 
and typical symptoms do not require biopsy. Intestinal 
biopsy is useful in the differential diagnosis of other 
gastrointestinal diseases [8, 9].
The aim of celiac disease therapy is to restore 
bowel function, normalise body weight and correct НЕОНАТОЛОГІЯ, ХІРУРГІЯ ТА ПЕРИНАТАЛЬНА МЕДИЦИНА             Т. ХIІІ, № 2(48), 2023
NEONATOLOGY, SURGERY AND PERINATAL MEDICINE                 VOL. ХIІІ, № 2(48), 2023
                                                                                                 
ISSN 2226-1230 (PRINT)  ISSN 2413-4260 (ONLINE)KEY TITLE: NEONATOLOGìâ, hìRURGìâ TA  PERINATALʹNA  MEDICINA  (ONLINE)
AbbREVIATED KEY  TITLE: NEONATOL. hìR. PERINAT . MED. (ONLINE)63deficiencies in essential nutrients [10, 11].
The pathogenetic treatment is a gluten-free diet 
to avoid the offending factor. It is necessary to 
follow a gluten-free diet for life. This leads to the 
disappearance of symptoms and normalisation of 
bowel activity.
Gluten is found in the following products: bread 
and all products made from wheat, rye, barley and 
oat flour, pasta, semolina. In small concentrations, 
gluten can be found in sausages and hot dogs, 
tinned meat and fish, mayonnaise and ketchup, 
various sauces, instant coffee and cocoa powder, 
chocolate, ice cream, soy products, instant soups, 
bouillon cubes, etc. Patients with newly diagnosed 
celiac disease should be screened for iron deficiency 
anaemia and vitamin D deficiency. As the gluten-
free diet is associated with vitamin and trace element 
deficiencies, multivitamins are recommended.
While the patient is on a gluten-free diet, the 
specific serological test (tTG-IgA) should be repeated 
approximately every six months; if it becomes 
normal - annually. A decrease in the antibody titer 
indicates compliance with the diet and confirms the 
diagnosis of celiac disease [8].
A gluten-free diet should not be started before 
serological testing for celiac disease, as these tests 
can be false negative. In children with an inconclusive 
diagnosis, reintroduction of gluten is prescribed after 
a gluten-free diet. In patients on a gluten-free diet with 
persistent symptoms and histological abnormalities 
or increased titres of serum antibodies, it is necessary 
to exclude secondary lactose intolerance, irritable 
bowel syndrome, bacterial overgrowth in the small 
intestine, diseases associated with atrophy of the 
villi of the small intestine. Refractory celiac disease 
is very rare in children.
Gluten intolerance is the most common gluten-
related syndrome, with a prevalence of 0.5% to 
13% in the general population [12,13]. Diagnosis is 
made by excluding other gluten-related conditions 
such as celiac disease and wheat allergy in children 
with persistent intestinal/extraintestinal symptoms 
associated with gluten consumption. Gluten 
intolerance is not associated with autoimmune lesions 
of the small intestine, thyroid, pancreas, liver, etc. 
To confirm this diagnosis, the child is prescribed 
a gluten-free diet for at least 4 weeks, after which 
gluten is reintroduced. The rapid disappearance 
of symptoms on a gluten-free diet and their rapid 
reappearance on reintroduction of gluten confirms 
gluten intolerance.
The aim  is to determine features of the 
course, serological and morphological features for 
differential diagnosis and management of celiac 
disease and gluten intolerance.
Material and methods
Our study included 30 children who were admitted 
between 2016 and 2023. Their age ranged from 9 
months to 11 years. Gender distribution: 13 (43.3%) 
boys and 17 (56.6%) girls, p=0.1391.
The study included a detailed review of medical 
history, family history and analysis of medical 
records, evaluation of the child's examination, 
anthropometric measurements. Determination of total titer of IgA antibodies, tTG-IgA, EMA-IgA, gliadin-
IgG. Allergy to wheat was excluded by evaluation of 
IgE antibodies to wheat. Endoscopy and biopsy were 
performed in children with tTG-IgA titres less than 
10 times the upper limit of normal. 
The study was approved by the Commission 
on Biomedical Ethics for Compliance with Moral 
and Legal Rules of Medical-Scientific Research of 
the Kharkiv National Medical University. It was 
confirmed that the research does not contradict 
the basic bioethical norms and complies with the 
main provisions of the Good Clinical Practice 
(1996), the Convention of the Council of Europe 
on Human Rights and Biomedicine (04.04.1997), 
the Declaration of Helsinki of the World Medical 
Association on the ethical principles of research 
involving human subjects (1964-2008), and the 
Order of the Ministry of Health of Ukraine No. 
690 (23.09.2009) with amendments according to 
the Order of the Ministry of Health of Ukraine No. 
523 (12.07.2012). Both parents of the patients were 
informed about the purpose and procedures of the 
research and signed the informed consent for their 
children's participation in this study. 
Statistical analysis was performed using 
Statistica 7.0 StatSoft Inc.1984-2004, (serial number 
12255555555, USA) and MedCalc version 14.8-© 
1993-2014 MedCalc Software bvba (Acacialaan 22 
B-8400 Ostend, Belgium). The procedures, logic and 
interpretation of the statistical parameters obtained in 
the mathematical and statistical analysis were based 
on generally accepted rules of medical and biological 
statistics. Descriptive analysis and comparison of 
two proportions were used. Non-parametric methods 
were used to test hypotheses: Logistic regression 
analysis using the relative risk index (RR) and 
its 95% confidence interval (CI). Differences in 
parameters were considered statistically significant 
if p<0.05. Patients in the study were divided into two 
groups according to the diagnosis of celiac disease 
and gluten intolerance.
The presented article is a fragment of the scientific 
research of the Department of Paediatrics No.1 
and Neonatology of the Kharkiv National Medical 
University: topic "Medical and social adaptation 
aspects of children with somatic pathology in modern 
conditions"; state registration No.0120U102471. 
Results
Demographic, clinical and laboratory 
characteristics of the children are shown in Table 
1. In the general cohort, 20 (66.6%) children were 
diagnosed with celiac disease and 10 (33.3%) children 
had gluten intolerance, p=0.0053. The mean age of 
the children with celiac disease was 8.4±1.0 years. 
Gender distribution among children with celiac 
disease - 10 (50.0%) boys, 10 (50.0%) girls, p=1.0000. 
The mean age of the children with gluten intolerance 
was 9.1±1.0 years. The gender distribution among the 
children with gluten intolerance was 7 (70.0%) boys 
and 3 (30.0%) girls, p=0.0001.
In 13 (65.0%) children with celiac disease, the 
diagnosis was confirmed at an earlier stage than in 
children with gluten intolerance, p=0.0350.
All patients with celiac disease were seropositive 
for serological biomarkers. In 19 (95.0%) children with РЕЗУЛЬТАТИ ДИСЕРТАЦІЙНИХ ТА НАУКОВО – ДОСЛІДНИХ РОБІТ/ RESULTS OF DISSERTATIONS AND RESEARCH WORKS64celiac disease, IgA to tissue transglutaminase tTG-IgA 
was detected (RR=20.4; 95% CI 1.4-307.2; p=0.0292). 
In 3 (30.0%) children with gluten intolerance, the level 
of IgG anti-gliadin antibodies was elevated (RR=1.0; 
95% CI 0.3-3.2; p=1.0000), but IgA antibodies to tissue 
transglutaminase and endomysium were not detected in any of the children. Autoimmune pathology in the 
family history was found in 8 children with celiac 
disease, confirming an autoimmune mechanism in its 
development [14]. Antibodies to wheat were measured 
in 15 children from the general group: all results were 
negative. Allergy to wheat was therefore excluded.НЕОНАТОЛОГІЯ, ХІРУРГІЯ ТА ПЕРИНАТАЛЬНА МЕДИЦИНА             Т. ХIІІ, № 2(48), 2023
NEONATOLOGY, SURGERY AND PERINATAL MEDICINE                 VOL. ХIІІ, № 2(48), 2023
                                                                                                 
ISSN 2226-1230 (PRINT)  ISSN 2413-4260 (ONLINE)KEY TITLE: NEONATOLOGìâ, hìRURGìâ TA  PERINATALʹNA  MEDICINA  (ONLINE)
AbbREVIATED KEY  TITLE: NEONATOL. hìR. PERINAT . MED. (ONLINE)
No significant differences were found in the 
comparative analysis of intestinal and extraintestinal 
manifestations in children with celiac disease 
and gluten intolerance (Figure 1). Diarrhoea and 
abdominal pain were found in 18/30 children of the 
general cohort (RR=0.8; 95% CI 0.4-1.4; p=0.5050), 
loss of appetite in 17/30 children (RR=0.7; 95% CI 
0.4-1.3; p=0. 2695), 15/30 children had constipation 
and poor weight gain (RR=0.7; 95% CI 0.3-1.5; 
p=0.4209), 14/30 children had delayed physical 
development and weakness (RR=0.9; 95% CI 0.4-1.9; 
p=0.7929). One third of the children had attention 
deficit hyperactivity disorder and sleep disturbances. 
Associated pathologies of children with celiac 
disease and gluten intolerance are the following: iron 
deficiency anaemia in 11/30 children (RR=1.3; 95% 
CI 0.4-3.9; p=0.6044), protein-energy deficiency in 
9/30 children (RR=0.6; 95% CI 0.2-1.8; p=0.3908), 
irritable bowel syndrome - 8/30 children (RR=0.8; 95% 
CI 0.2-2. 8; p=0.7684), subclinical hypothyroidism - 
3/30 children (RR=3.6; 95% CI 0.2-64.8; p=0.3752), 
chronic gastroduodenitis - 2/30 children (RR=2.6; 
95% CI 0.1-49.9; p=0. 5220), chronic pancreatitis - 
1/30 children (RR=1.6; 95% CI 0.1-35.4; p=0.7762), 
autism spectrum disorders - 1/30 children (RR=0.2; 95% CI 0.1-3.9; p=0.2724), (Fig. 2).
Morphological analysis of biopsies of the small 
intestinal mucosa was performed in 15 (50%) 
children with celiac disease and in 6 (60%) with 
gluten intolerance. All children with celiac disease 
had different stages of mucosal atrophy according 
to the Marsh-Oberhuber classification. No atrophic 
changes in the small intestinal mucosa were found 
in children with gluten intolerance (normal structure 
of villi and crypts), but infiltrative changes were 
found in 6 (60%) children (increase of intraepithelial 
lymphocytes).
We present our clinical cases for illustration.
Clinical case No.1
A 9-month-old girl was admitted to the pediatric 
gastroenterology department. The girl's mother 
complains of her daughter's lack of weight gain for 2 
months, loose stools up to 5-6 times a day, vomiting 
after meals 1-2 times a week, tearfulness, sleep 
disturbances.
Medical history. Stool is liquid, abundant up to 
5-6 times a day, observed from the 6th month of 
life, after the introduction of complementary foods. 
Complaints of periodic vomiting, loss of appetite, 
flatulence, present since 7 months. Faecal analysis Table 1
Demographic, clinical and laboratory data of children with coeliac disease and gluten intolerance, abs., (%)
DataChildren with celiac 
disease,
n=20Children 
with gluten 
intolerance,
n=10p
1-4 years 12 (60,0) 7 (70,0) 0,2181
4-7 years 6 (30,0) 2 (20,0) 0,2211
7-11 years 2 (10,0) 1 (10,0) 0,5000
Girls 10 (50,0) 3 (30,0) 0,1487
Boys 10 (50,0) 7 (70,0) 0,1487
Autoimmune pathology in the family history 8 (40,0) 0 (2,9) 0,0160
Positive Ig A to tTG 19 (95,0) 0 (2,9) 0,0001
Positive Ig G to gliadin 6 (30,0) 3 (30,0) 0,5000
Normal level of total Ig A 20 (100,0) 10 (100,0) 0,5000
Positive antibodies to endomysium (EMA-IgA) 6 (30,0) 0 (2,9) 0,1231
Negative antibodies to endomysium (EMA-IgA) 14 (70,0) 10 (100,0) 0,0350
Deficiency of 25-OH-D3 8 (40,0) 3 (30,0) 0,1367
Deficiency anaemia 12 (60,0) 4 (40,0) 0,0450
Constipation 8 (40,0) 3 (30,0) 0,1367
Diarrhoea 12 (60,0) 7 (70,0) 0,1419
Abdominal pain 9 (45,0) 4 (40,0) 0,3801
Abdominal bloating 13 (65,0) 6 (60,0) 0,2181
Loss of appetite 10 (50,0) 5 (50,0) 0,5000
Weakness 8 (40,0) 4 (40,0) 0,5000
Delay in physical development 9 (45,0) 5 (50,0) 0,2192
Sleep disturbances 5 (25,0) 3 (30,0) 0,2797
Psychomotor and speech development retardation 8 (40,0) 5 (50,0) 0,1487
Attention deficit hyperactivity disorder 6 (30,0) 3 (30,0) 0,500065for intestinal group microbes is repeatedly negative.
She was born in the third pregnancy without 
complications; third delivery by caesarean section 
with Apgar score 8/9, birth weight 4000 g, height 55 
cm. The girl was breastfed for up to 1 month, then 
weaned on a special formula. Due to the low income 
of the family, the baby was also fed with semolina 
and oatmeal porridge. The mother periodically 
offered the child bread and biscuits. Development is 
delayed: does not sit or stand. Babbles - on time.
Allergy anamnesis: diaper dermatitis at age of 3 
months.
Family anamnesis: child's mother periodically 
complains of abdominal pain and loose stool.
The child's general condition is moderate. 
Delayed physical development. The child's weight 
on admission was 6,600 g, height 72 cm. Deficit in 
body weight - 25.5%. Muscular hypotonia of limbs 
and anterior abdominal wall, protruding forehead 
and parietal humps. Skin was pale, clear, dry. The 
subcutaneous fat layer is thin on the abdomen, trunk 
and limbs. Abdomen is soft, moderately distended, 
painless, liver is palpable +2.5 cm below the costal 
arch. Stool is type 7 on the Bristol chart.
The differential diagnosis included celiac disease, 
gluten intolerance and wheat allergy. Examinations:
- CBC: iron deficiency anaemia.
- Urinalysis, stool test, urine amylase test – 
normal findings.
- D(25(OH)) – 15 ng/ml (reference value – 30-70 
ng/ml).
- IgA in blood serum - 0.4 g/l. (reference value – 
0.02-0.83 g/l).
- IgG autoantibodies to gliadin 35.2 IU/ml (up to 
1 year up to 3 IU/ml).
- IgA autoantibodies to tTG less than 1 IU/ml (reference value – less than 20 IU/ml).
- IgG autoantibodies to tTG 14.5 IU/ml (reference 
value – less than 20 IU/ml).
- IgA antibodies to endomysium – titre 1:5 
(reference value – less 1:10 – negative).
- Abdominal ultrasound: liver size +1 cm.
- - Endoscopy: erythematous duodenopathy, mild, 
with elements of lymphofollicular hyperplasia of the 
duodenal mucosa. Pathomorphological conclusion: 
normal histostructure of the mucosa.
Diagnosis: Gluten intolerance. Vitamin 
D-deficient rickets. Moderate protein-energy 
deficiency.
The child was prescribed a gluten-free diet and the 
nutritional status was corrected (including vitamin 
D). Positive dynamics of intestinal symptoms, body 
weight and psychomotor development were noted 
within 6 months.
Clinical case No.2
Girl P., 1 year 4 months old, parents complain 
about the baby's lethargy, anxiety, abdominal 
distension, weight loss, defecation disorders 
(alternation of small amounts of stool with periodic 
watery stool, up to 5-6 times a day).
The child was born from the first pregnancy 
against the background of anaemia and mild pre-
eclampsia, Apgar score 7/8, body weight 3000 g, 
body length 50 cm.
The girl was breastfed up to 3 months, then due 
to hypogalactia of the mother she was transferred 
to artificial feeding with adapted milk formula. 
This resulted in hyperemia and dry skin. Cereals 
(including oatmeal) were introduced at 6 months. 
Stool was mushy, 1-2 times a day.
The girl has been growing and developing 
normally by the age of one year.РЕЗУЛЬТАТИ ДИСЕРТАЦІЙНИХ ТА НАУКОВО – ДОСЛІДНИХ РОБІТ/ RESULTS OF DISSERTATIONS AND RESEARCH WORKS
Fig. 1 Intestinal and extra-intestinal manifestations in children 
with celiac disease and gluten intolerance66At the age of 1 year and 2 months, vomiting 
occurred up to 3 times a day, loose stools - up to 3 
times a day, no fever. Examined by a paediatrician: 
preliminary diagnosis - teething. In 5 days motor 
activity decreased, abdominal distension appeared, 
stool became more frequent up to 5-6 times a day, 
liquid. Despite good appetite, the child began to lose 
weight and was admitted to the paediatric infectious 
diseases department with a diagnosis of acute 
enterocolitis. No positive dynamics on treatment, 
so the girl was transferred to the gastroenterology 
department because of suspicion of gluten 
enteropathy.
The state on admission was severe because of 
the asthenic and dyspeptic syndrome. Body weight 
deficit was about 12% (weight on admission - 9,640 
g, correct weight - 11,000 g). Skin: pale, greyish, 
dry. The subcutaneous fat layer was slightly thinned. 
Muscle tone was diffusely reduced. Auscultation of 
the lungs: childish breathing, no wheezing. Heart 
sounds were rhythmic, muffled. The abdomen was 
enlarged, distended. There was a rumbling sound 
along the colon. Symptoms of peritoneal irritation 
were negative. Liver: +3 cm below the costal arch. 
Stool: once a day with a small amount of faeces. 
Urine: transparent, pale yellow.
Examinations:
- CBC: mild hypochromic anaemia (haemoglobin 
– 9.0 g/ml, microcytosis, anisocytosis, colour index 
– 0.78).
- Biochemical blood test: decrease of total protein, 
hypalbuminaemia, iron – 6.2 nmol/l (reference value 
– 8.8-27 nmol/l), ferritin – 4.6 ng/ml (reference 
value – 7-140 ng / ml). 
- Urinalysis – normal findings.
- Stool test: steatorrhea, amylorrhoea, moderate 
amount of mucus.
- Faecal bacteriology: moderate growth of E. coli.
- Serum IgA - 0.83 g/l (reference value – 0.2-1 g/l).- Immunoglobulin IgA to tTG - 220 IU/ml 
(reference value – less than 20 IU/ml).
- Abdominal ultrasound: diffuse changes in the 
liver parenchyma; a lot of content in the stomach, 
increased peristalsis of the lower intestine, liquid 
content.
- Colon X-ray: shape of the colon is changed; 
contours of the intestine are even, wall is elastic, 
no defects, lumen is patent and narrowing after 
defecation.
- Endoscopy: normal colour of mucosa 
oesophagus, stomach and duodenum. Cardia is 
closed. Biopsy was taken. Histological examination 
of the duodenum mucous membrane: flattening of 
the villi, oedema and moderate lymphoplasmacytic 
infiltration of the stroma.
- Endoscopic rectosigmoidoscopy: catarrhal 
proctosigmoiditis.
Diagnosis: Celiac disease, typical form. 
Megacolon. Mild iron deficiency anaemia. Protein-
energy deficiency of the 1st degree.
The girl received treatment: therapeutic polymer 
nutrition (water-based porridges, like buckwheat and 
corn, were introduced 5 days later); infusion therapy 
with glucose-saline solutions, antibiotics, vitamins, 
enzymes, probiotics. During her stay at the hospital, 
symptoms of intoxication disappeared, appetite 
became normal, stool – regular, digested; she began 
gaining weight, standing up, and walking.
The child was discharged home with the 
recommendations: strict gluten-free diet, 
supplementation of vitamins B1, B6, D.
Discussion
Symptoms of gluten-dependent diseases usually 
appear in children after ingestion of gluten at the 
age of 4-24 months [4]. In our study, the mean age 
at diagnosis of celiac disease was 2.8±1.3 years. 
Major gastrointestinal symptoms such as diarrhoea 
and abdominal distension are observed in 50% of НЕОНАТОЛОГІЯ, ХІРУРГІЯ ТА ПЕРИНАТАЛЬНА МЕДИЦИНА             Т. ХIІІ, № 2(48), 2023
NEONATOLOGY, SURGERY AND PERINATAL MEDICINE                 VOL. ХIІІ, № 2(48), 2023
                                                                                                 
ISSN 2226-1230 (PRINT)  ISSN 2413-4260 (ONLINE)KEY TITLE: NEONATOLOGìâ, hìRURGìâ TA  PERINATALʹNA  MEDICINA  (ONLINE)
AbbREVIATED KEY  TITLE: NEONATOL. hìR. PERINAT . MED. (ONLINE)
Fig. 2. Associated pathology in children with gluten-dependent diseases67patients with gluten-dependent diseases [15, 16]. In 
our study, these symptoms were found in 60% of the 
children.
Extra-intestinal manifestations are observed in 
60% of children with gluten-dependent diseases, and 
physical developmental delay is the most common 
problem [17]. According to the authors, up to 47% 
of children with gluten-dependent diseases have 
physical developmental delay, which is similar to the 
results of our study [15, 18, 21].
Iron deficiency anaemia is present in 40% of 
children with gluten-dependent disorders [18, 20]. 
In our study, 60% of children with celiac disease 
and 40% of children with gluten intolerance had 
iron deficiency anaemia. According to the literature, 
extraintestinal symptoms predominate in adult 
patients with gluten intolerance [14]. The results 
of our study show that there are no significant 
differences in the clinical manifestations of celiac 
disease and gluten intolerance. According to some 
authors, the prevalence of celiac disease in patients 
with autoimmune pathology is 3.0%-4.8% [15, 21]. 
In our study, 6.6% of the children had autoimmune 
thyroiditis. Other authors have found that 10-30% 
of children with gluten-dependent diseases have a 
25-OH-D3 deficiency [22]. We found that 40% of 
children with celiac disease and 30% of children 
with gluten intolerance had 25-OH-D3 deficiency.
The 2020 ESPGHAN guidelines report: The 
combination of tTG-IgA and total IgA test results 
is more accurate than other test combinations as an 
initial investigation in suspected gluten-dependent 
diseases. In our study, 95% of children with celiac 
disease were positive for tTG-IgA, while all children 
with gluten intolerance were negative. This is 
important for differential diagnosis [6,8].
There is also evidence in the scientific literature 
that celiac disease is characterised by autoimmune 
lesions of the small intestine with development of 
mucosal atrophy, and that only clinical symptoms 
without structural damage to the small intestinal 
mucosa are typical of gluten intolerance [23]. In 
our study, different stages of atrophy of the small 
intestinal mucosa according to the Marsh-Oberhuber 
classification were found in all children with celiac 
disease, and no atrophic changes were found in 
children with gluten intolerance.Currently, the only effective treatment for gluten-
dependent disorders is a gluten-free diet [24, 25]. 
Children in our study with a confirmed diagnosis 
were placed on a gluten-free diet. Improvement in 
clinical symptoms was seen after 4-6 weeks.
Conclusion
The results of our study indicate that there are no 
significant differences in the clinical manifestations 
of celiac disease and gluten intolerance. Gluten 
intolerance is diagnosed after exclusion of 
autoimmune nosology in the family history; 
absence of autoantibodies to tTG, endomysium 
and deaminated gliadin peptides determined on a 
gluten-containing diet; absence of specific IgE to 
wheat; without total IgA deficiency. An important 
step is the morphological analysis of biopsies of 
the small intestinal mucosa. Different stages of 
mucosal atrophy according to the Marsh-Oberhuber 
classification are characteristic of celiac disease, 
whereas they are not typical of gluten intolerance, 
but initial changes in the small intestinal mucosa 
can be detected: a slight increase in intraepithelial 
lymphocytes. Clear algorithms proposed by 
ESPHGAN and the World Gastroenterological 
Organisation will help in the differential diagnosis 
of gluten-dependent diseases. In children with 
unexplained chronic diarrhoea, delayed physical 
development, delayed puberty, nausea, vomiting, 
abdominal pain and bloating, chronic constipation, 
iron deficiency anaemia and elevated liver enzymes, 
gluten-related diseases should be excluded. Cases 
have shown significant improvement in children 
on a gluten-free diet, despite delayed physical 
development, impaired protein-energy metabolism 
and poor absorption of vitamins and minerals. Early 
diagnosis and treatment of coeliac disease prevents 
the development of serious complications and the 
manifestation of autoimmune diseases. 
Prospects for further research:  determination 
of criteria for early diagnosis, management for 
children with gluten-related diseases.
Conflict of interest:  none.
Funding: self-financing.РЕЗУЛЬТАТИ ДИСЕРТАЦІЙНИХ ТА НАУКОВО – ДОСЛІДНИХ РОБІТ/ RESULTS OF DISSERTATIONS AND RESEARCH WORKS68НЕОНАТОЛОГІЯ, ХІРУРГІЯ ТА ПЕРИНАТАЛЬНА МЕДИЦИНА             Т. ХIІІ, № 2(48), 2023
NEONATOLOGY, SURGERY AND PERINATAL MEDICINE                 VOL. ХIІІ, № 2(48), 2023
                                                                                                 
ISSN 2226-1230 (PRINT)  ISSN 2413-4260 (ONLINE)KEY TITLE: NEONATOLOGìâ, hìRURGìâ TA  PERINATALʹNA  MEDICINA  (ONLINE)
AbbREVIATED KEY  TITLE: NEONATOL. hìR. PERINAT . MED. (ONLINE)
References:
1. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global Prevalence of Celiac Disease: 
Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol [Internet]. 2018[cited 2023 May 28];16(6):823-36.
e2. Available from: https://www.cghjournal.org/article/S1542-3565(17)30783-8/fulltext doi: 10.1016/j.cgh.2017.06.037
2. Myléus A, Reilly NR, Green PHR. Rate, Risk Factors, and Outcomes of Nonadherence in Pediatric Patients With 
Celiac Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2020;18(3):562-73. doi: 10.1016/j.cgh.2019.05.046
3. Catassi GN, Pulvirenti A, Monachesi C, Catassi C, Lionetti E. Diagnostic Accuracy of IgA Anti-Transglutaminase 
and IgG Anti-Deamidated Gliadin for Diagnosis of Celiac Disease in Children under Two Years of Age: A Systematic 
Review and Meta-Analysis. Nutrients [Internet]. 2021[cited 2023 May 28];14(1):7. Available from: https://www.mdpi.
com/2072-6643/14/1/7 doi: 10.3390/nu14010007 
4. Husby S, Koletzko S, Korponay-Szabó I, Kurppa K, Mearin ML, Ribes-Koninckx C, et al. European Society 
Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr 
Gastroenterol Nutr. 2020;70(1):141-56. doi: 10.1097/MPG.0000000000002497
5. Malik  Z. Celiac Disease (Gluten Enteropathy). MSD Manual for the Professional, 2021.  Available from: https://
www.msdmanuals.com/uk/professional/gastrointestinal-disorders/malabsorption-syndromes/celiac-disease
6. European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), 2020. New Guidelines 
for the Diagnosis of Paediatric Coeliac Disease. Available from: https://www.espghan.org/knowledge-center/publications/
Clinical-Advice-Guides/2020_New_Guidelines_for_the_Diagnosis_of_Paediatric_Coeliac_Disease 
7. Auricchio R, Mandile R, Del Vecchio MR, Scapaticci S, Galatola M, Maglio M, et al. Progression of Celiac Disease 
in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture. Gastroenterology 
[Internet]. 2019[cited 2023 May 28];157(2):413-20.e3. Available from: https://www.gastrojournal.org/action/showPdf?p
ii=S0016-5085%2819%2935671-9 doi: 10.1053/j.gastro.2019.04.004
8. Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, et al. American College of Gastroenterology 
Guidelines Update: Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2023;118(1):59-76. doi: 10.14309/
ajg.0000000000002075
9. Wessels M, Dolinsek J, Castillejo G, Donat E, Riznik P, Roca M, et al. Follow-up practices for children and 
adolescents with celiac disease: results of an international survey. Eur J Pediatr. 2022;181(3):1213-20. doi: 10.1007/
s00431-021-04318-2
10. Hill ID, Fasano A, Guandalini S, Hoffenberg E, Levy J, Reilly N, et al. NASPGHAN Clinical Report on the 
Diagnosis and Treatment of Gluten-related Disorders. J Pediatr Gastroenterol Nutr. 2016;63(1):156-65. doi: 10.1097/
MPG.0000000000001216
11. Valitutti F, Trovato CM, Montuori M, Cucchiara S. Pediatric Celiac Disease: Follow-Up in the Spotlight. Adv 
Nutr. 2017;8(2):356-61. doi: 10.3945/an.116.013292
12. Francavilla R, Cristofori F, Verzillo L, Gentile A, Castellaneta S, Polloni C, et al. Randomized Double-Blind 
Placebo-Controlled Crossover Trial for the Diagnosis of Non-Celiac Gluten Sensitivity in Children. Am J Gastroenterol. 
2018;113(3):421-30. doi: 10.1038/ajg.2017.483 
13. Khan A, Suarez MG, Murray JA. Nonceliac Gluten and Wheat Sensitivity. Clin Gastroenterol Hepatol [Internet]. 
2020[cited 2023 May 28];18(9):1913-22.e1. Available from: https://www.cghjournal.org/article/S1542-3565(19)30367-
2/fulltext doi: 10.1016/j.cgh.2019.04.009 
14. Sapone A, Leffler DA, Mukherjee R. Non-Celiac Gluten Sensitivity – Where are We Now in 2015? Pract 
Gastroenterol. 2015;143:40-48. 
15. Sahin Y . Clinical evaluation of children with celiac disease: a single-center experience. Arch Clin Gastroenterol 
[Internet]. 2020[cited 2023 May 28];6:026-030. Available from: https://www.peertechzpublications.com/articles/ACG-6-
174.php doi: 10.17352/2455-2283.000074
16. Llanos-Chea A, Fasano A. Gluten and Functional Abdominal Pain Disorders in Children. Nutrients [Internet]. 
2018[cited 2023 May 28];10(10):1491. Available from: https://www.mdpi.com/2072-6643/10/10/1491 doi: 10.3390/
nu10101491 
17. Nardecchia S, Auricchio R, Discepolo V , Troncone R. Extra-Intestinal Manifestations of Coeliac Disease in 
Children: Clinical Features and Mechanisms. Front Pediatr [Internet]. 2019[cited 2023 May 28];7:56. Available from: 
https://www.frontiersin.org/articles/10.3389/fped.2019.00056/full doi: 10.3389/fped.2019.00056
18. Jericho H, Guandalini S. Extra-Intestinal Manifestation of Celiac Disease in Children. Nutrients [Internet]. 
2018[cited 2023 May 28];10(6):755. Available from: https://www.mdpi.com/2072-6643/10/6/755 doi: 10.3390/
nu10060755
19. Nardecchia S, Auricchio R, Discepolo V , Troncone R. Extra-Intestinal Manifestations of Coeliac Disease in 
Children: Clinical Features and Mechanisms. Front Pediatr [Internet]. 2019[cited 2023 May 28];7:56. Available from: 
https://www.frontiersin.org/articles/10.3389/fped.2019.00056/full doi: 10.3389/fped.2019.00056
20. Nurminen S, Kivelä L, Huhtala H, Kaukinen K, Kurppa K. Extraintestinal manifestations were common in children 
with coeliac disease and were more prevalent in patients with more severe clinical and histological presentation. Acta 
Paediatr. 2019;108(4):681-7. doi: 10.1111/apa.14324
21. Sahin Y , Evliyaoglu O, Erkan T, Cokugras FC, Ercan O, Kutlu T. The frequency of celiac disease in children with 
autoimmune thyroiditis. Acta Gastroenterol Belg. 2018;81(1):5-8. 
22. Björck S, Brundin C, Karlsson M, Agardh D. Reduced Bone Mineral Density in Children With Screening-detected 
Celiac Disease. J Pediatr Gastroenterol Nutr. 2017;65(5):526-32. doi: 10.1097/MPG.0000000000001568
23. Rotondi Aufiero V , Fasano A, Mazzarella G. Non-Celiac Gluten Sensitivity: How Its Gut Immune Activation 
and Potential Dietary Management Differ from Celiac Disease. Mol Nutr Food Res [Internet]. 2018[cited 2023 May 
28];62(9):e1700854. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/mnfr.201700854 doi: 10.1002/
mnfr.201700854
24. Trovato CM, Montuori M, Valitutti F, Leter B, Cucchiara S, Oliva S. The Challenge of Treatment in Potential 
Celiac Disease. Gastroenterol Res Pract [Internet]. 2019[cited 2023 May 28];2019:8974751. Available from: https://
downloads.hindawi.com/journals/grp/2019/8974751.pdf doi: 10.1155/2019/8974751
25. Al-Toma A, V olta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, et al. European Society for the Study of 
Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol 
J. 2019;7(5):583-613. doi: 10.1177/205064061984412569РЕЗУЛЬТАТИ ДИСЕРТАЦІЙНИХ ТА НАУКОВО – ДОСЛІДНИХ РОБІТ/ RESULTS OF DISSERTATIONS AND RESEARCH WORKS
ПРОБЛЕМИ ДИФЕРЕНЦІЙНОЇ ДІАГНОСТИКИ ЦЕЛІАКІЇ 
ТА НЕПЕРЕНОСИМОСТІ Г ЛЮТЕНУ У ДІТЕЙ 
Г. Сенаторова1, О. Омельченко1, Т. Тесленко1, Г. Муратов2, Н. Орлова1, К. Чатикян2 
Харківський національний медичний університет (Харків, Україна)1 
Харківська обласна дитяча клінічна лікарня (Україна)2
Резюме
Вступ. На сьогодні у клінічній практиці виділяють 3 види «глютенозалежних захворювань»: целіакія, непереносимості 
глютену без целіакії (НГБЦ) і алергія на злакові, зокрема пшеницю. Целіакія – це хронічне, імунозапальне захворювання, 
яке виникає у генетично схильних осіб у відповідь на контакт із основним білком злакових – глютеном, і характеризується 
ураженням слизової оболонки тонкої кишки та призводить до розвитку її атрофії із відповідними клінічними кишковими 
та позакишковими проявами; лікується за допомогою пожиттєвої безглютенової дієти. НГБЦ – це стан, який характеризу -
ється появою симптоматики, подібної до синдрому подразненого кишечника, за декілька годин або днів після споживання 
глютеновмісних страв. Ці прояви швидко зникають після припинення споживання глютеновмісних продуктів. Причинами 
НГБЦ є інгібітори амілази, трипсину та фруктани (FODMAPS), які є складовими пшениці та інших глютеновмісних та без -
глютенових продуктів харчування. У 2020 році з’явилися нові рекомендації Європейського товариства педіатрії, гастроен -
терології, гепатології та нутриціології (ESPGHAN) для діагностики целіакії у дітей. Діагноз НГБЦ потребує виключення 
целіакії та алергії на пшеницю.
Метою дослідження було визначити особливості клінічного перебігу целіакії та НГБЦ (проаналізувати кишкові та 
позакишкові симптоми), серологічні та морфологічні характеристики для диференціальної діагностики та визначення так -
тики ведення дітей.
Матеріал та методи дослідження.  До дослідження було залучено 30 дітей за період 2016-2023 роки, віком від 9 міся -
ців до 11 років; 13 (43,3%) хлопчиків і 17 (56,6%) дівчаток, р=0,1391. Дослідження включало детальне вивчення анамнезу, 
оцінку об’єктивного огляду дитини, фізичного розвитку. Визначення загального титру антитіл IgA, IgA до тканинної тран -
сглутамінази (tTG-IgA), ендомізію IgA (ЕМА-IgA), гліадину IgG, антитіл до пшениці IgE, ендоскопію та морфологічне до -
слідження біоптатів слизової оболонки дванадцятипалої кишки. Використовували описовий аналіз, порівняння двох про -
порцій (непараметричні методи для перевірки висунутих у роботі гіпотез: логістична регресія з використанням показника 
відносного ризику (RR) і 95% довірчого інтервалу (CI). Різницю параметрів вважали статистично значущою при р<0,05.
Дослідження погоджено Комісією з питань біомедичної етики щодо дотримання морально-правових правил проведен -
ня медичних наукових досліджень Харківського національного медичного університету. Встановлено, що дослідження не 
суперечать основним біоетичним нормам і відповідають основним положенням GCP (1996), Конвенції Ради Європи з прав 
людини та біомедицини (04.04.1997), Гельсінкської декларації. Всесвітньої медичної асоціації з етичних засад досліджен -
ня за участю людини (1964-2008) та наказу МОЗ України №690 від 23.09.2009 (зі змінами, внесеними згідно з наказом МОЗ 
України № 523 від 12.07.2012). Обидва батьки пацієнтів були поінформовані про мету й обсяг дослідницьких процедур і 
підписали інформовану письмову згоду на участь їхніх дітей у даному дослідженні.
Статистичний аналіз було проведено за допомогою програм Statistica 7.0 StatSoft Inc.1984-2004, (Serial Number 
12255555555, USA) and MedCalc version 14.8-© 1993-2014 MedCalc Software bvba (Acacialaan 22 B-8400 Ostend, Belgium). 
Процедури, логіка та інтерпретація одержаних статистичних параметрів математично-статистичного аналізу базувалися 
на загальноприйнятих положеннях медичної та біологічної статистики. Використовували описовий аналіз, порівняння 
двох пропорцій. Використовували непараметричні методи для перевірки висунутих у роботі гіпотез: логістична регресія з 
використанням показника відносного ризику (RR) і 95% довірчого інтервалу (CI). Різницю параметрів вважали статистич -
но значущою при р<0,05. У процесі дослідження пацієнтів було розподілено на дві групи за діагнозом: целіакія та НГБЦ.
Представлена стаття є фрагментом науково-дослідної роботи кафедри педіатрії №1 та неонатології Харківського на -
ціонального медичного університету на тему: «Медико-соціальні аспекти адаптації дітей із соматичною патологією в су -
часних умовах» (номер державної реєстрації 0120U102471).
Результати дослідження. 
У 66,6% дітей із загальної когорти було встановлено діагноз целіакія, а у 33,3% дітей – НГБЦ, р=0,0053. Середній вік 
дітей із целіакією – 8,4±1,0 рік. Розподіл за статтю серед дітей з целіакією - 50,0% хлопчиків, 50,0% дівчаток, р=1,0000. Се -
редній вік дітей з НГБЦ – 9,1±1,0 рік. Розподіл за статтю серед дітей з НГБЦ - 70,0% хлопчиків і 30,0% дівчаток, р=0,0001. 
У 65,0% дітей із целіакією діагноз встановлюється на більш ранньому етапі, ніж у дітей із НГБЦ, р=0,0350. Обтяження 
сімейного анамнезу автоімунною патологією спостерігалось у 40% дітей з целіакією. Усі хворі на целіакію були серопо -
зитивними за серологічними біомаркерами. У 95,0% дітей з целіакією визначались IgA до тканинної трансглутамінази 
tTG-IgA (RR=20,4; 95% CI 1,4‒307,2; p=0,0292).
У 18/30 дітей із загальної когорти виявлено діарею та болі в животі (RR=0,8; 95% CI 0,4‒1,4; p=0,5050), у 17/30 дітей – 
зниження апетиту (RR=0,7; 95% CI 0,4‒1,3; p=0,2695), у 15/30 дітей – закреп і погану прибавку маси тіла (RR=0,7; 95% CI 
0,3‒1,5; p=0,4209), у 14/30 дітей – затримку фізичного розвитку і слабкість (RR=0,9; 95% CI 0,4‒1,9; p=0,7929). Синдром 
гіперактивності та дефіциту уваги, порушення нічного сну мала третина обстежених дітей. У всіх дітей із целіакією було 
виявлено різні стадії атрофії слизової оболонки тонкої кишки за класифікацією Marsh-Oberhuber. У дітей із НГБЦ не вияв -
лено атрофічних змін слизової оболонки тонкої кишки (ворсинки та крипти нормальної будови), однак у 60% цих пацієнтів 
виявлені інфільтративні зміни (збільшення інтраепітеліальних лімфоцитів).
Висновки. Під час проведення порівняльного аналізу достовірних відмінностей між клінічними проявами целіакії та 
НГБЦ не знайдено. У сімейному анамнезі дітей із НГБЦ автоімунна патологія не виявлена, тоді як у 40% пацієнтів із целі -
акією він був обтяжений. НГБЦ діагностують після виключення в родинному анамнезі автоімунної нозології; відсутності 
автоантитіл до тканьової транглутамінази та дезамінованим пептидам гліадину, ендомізіальних автоантитіл, які визна -
чаються на тлі глютен-вмісної дієти, а також відсутності специфічних IgE до пшениці. У всіх дітей із целіакією виявлені 
різні стадії атрофії слизової оболонки тонкої кишки за класифікацією Marsh-Oberhuber, а у дітей із НГБЦ атрофічних змін 
не знайдено, однак у 60% пацієнтів з НГБЦ виявлені інфільтративні зміни слизової оболонки тонкої кишки.
Ключові слова:  целіакія; непереносимість глютену без целіакії; безглютенова дієта; діти.70НЕОНАТОЛОГІЯ, ХІРУРГІЯ ТА ПЕРИНАТАЛЬНА МЕДИЦИНА             Т. ХIІІ, № 2(48), 2023
NEONATOLOGY, SURGERY AND PERINATAL MEDICINE                 VOL. ХIІІ, № 2(48), 2023
                                                                                                 
ISSN 2226-1230 (PRINT)  ISSN 2413-4260 (ONLINE)KEY TITLE: NEONATOLOGìâ, hìRURGìâ TA  PERINATALʹNA  MEDICINA  (ONLINE)
AbbREVIATED KEY  TITLE: NEONATOL. hìR. PERINAT . MED. (ONLINE)
Received for editorial office on 14/02/2023
Signed for printing on 17/05/2023Contact Information:
Ganna Senatorova  – Doctor of Medical Science, Full Professor, 
Professor of the Department of Pediatrics No.1 and Neonatology, 
Kharkiv National Medical University (Kharkiv, Ukraine).
E-mail:  ganna.senatorova@gmail.com 
ORCID ID:  https://orcid.org/0000-0001-6725-4695 
Olena Omelchenko  – Candidate of Medical Science, Docent, 
Associate Professor of the Department of Pediatrics No.1 and 
Neonatology, Kharkiv National Medical University (Kharkiv, 
Ukraine).
E-mail:  ov.omelchenko@knmu.edu.ua 
ORCID ID:  https://orcid.org/0000-0001-8728-8489 
Tetiana Teslenko – Candidate of Medical Science, Docent, 
Associate Professor of the Department of Pediatrics No.1 and 
Neonatology, Kharkiv National Medical University (Kharkiv, 
Ukraine).
E-mail: to.teslenko@knmu.edu.ua 
ORCID ID:  https://orcid.org/0000-0003-4725-334X 
Georgiy Muratov  – Candidate of Medical Science, Docent, 
Associate Professor of the Department of Pediatrics No.1 
and Neonatology, Kharkiv National Medical University, Chief 
of the Kharkiv Regional Children’s Clinical Hospital (Kharkiv, 
Ukraine).
E-mail:  hrmuratov.po19@knmu.edu.ua 
ORCID ID: https://orcid.org/0000-0002-5865-3747 
Natalia Orlova – Postgraduate Student of the Department of 
Pediatrics No.1 and Neonatology, Kharkiv National Medical 
University (Kharkiv, Ukraine).
E-mail:  norlova318@gmail.com 
ORCID ID:  https://orcid.org/0000-0002-6408-3058 
Krystyna Chatykian – trainee-physician of the Department 
of Pediatrics No.1 and Neonatology, Kharkiv National Medical 
University (Kharkiv, Ukraine).
E-mail:  kechatykian.int22@knmu.edu.ua 
ORCID ID:  https://orcid.org/0009-0003-0582-5925Контактна інформація:
Сенаторова Ганна Сергіївна  – доктор медичних наук, профе -
сор, професор кафедри педіатрії №1 та неонатології Харківсько -
го національного медичного університету (м. Харків, Україна).
E-mail:  ganna.senatorova@gmail.com 
ORCID:  https://orcid.org/0000-0001-6725-4695 
Омельченко Олена Володимирівна – кандидат медичних наук, 
доцент, доцент кафедри педіатрії №1 та неонатології Харківсько -
го національного медичного університету університету (м. Хар -
ків, Україна).
E-mail:  ov.omelchenko@knmu.edu.ua 
ORCID ID::  https://orcid.org/0000-0001-8728-8489 
Тесленко Тетяна Олександрівна  – кандидат медичних наук, 
доцент, доцент кафедри педіатрії №1 та неонатології Харків -
ського національного медичного університету університету (м. 
Харків, Україна).
E-mail: to.teslenko@knmu.edu.ua 
ORCID ID::  https://orcid.org/0000-0003-4725-334X 
Муратов Георгій Рафікович  – кандидат медичних наук, доцент, 
доцент кафедри педіатрії №1 та неонатології Харківського націо -
нального медичного університету, директор КНП ХОР «Обласна 
Дитяча Клінічна Лікарня» (м. Харків, Україна).
E-mail:  hrmuratov.po19@knmu.edu.ua 
ORCID ID: https://orcid.org/0000-0002-5865-3747 
Орлова Наталя Василівна  – аспірант кафедри педіатрії №1 та 
неонатології Харківського національного медичного університету 
(м. Харків, Україна).
E-mail:  norlova318@gmail.com 
ORCID ID: https://orcid.org/0000-0002-6408-3058 
Чатикян Кристина Едиківна  – лікар-інтерн кафедри педіатрії 
№1 та неонатології Харківського національного медичного уні -
верситету (м. Харків, Україна).
E-mail:  kechatykian.int22@knmu.edu.ua 
ORCID ID:  https://orcid.org/0009-0003-0582-5925 
